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Aim: The Danish Heart Registry (DHR) seeks to monitor nationwide activity and quality of 
invasive diagnostic and treatment strategies in patients with ischemic heart disease as well as 
valvular heart disease and to provide data for research.
Study population: All adult ($15 years) patients undergoing coronary angiography (CAG), 
percutaneous coronary intervention (PCI), coronary artery bypass grafting, and heart valve 
surgery performed across all Danish hospitals were included.
Main variables: The DHR contains a subset of the data stored in the Eastern and Western 
Denmark Heart Registries (EDHR and WDHR). For each type of procedure, up to 70 variables 
are registered in the DHR. Since 2010, the data quality protocol encompasses fulfillment of 
web-based validation rules of daily-submitted records and yearly approval of the data by the 
EDHR and WDHR.
Descriptive data: The data collection on procedure has been complete for PCI and surgery 
since 2000, and for CAG as of 2006. From 2000 to 2014, the number of CAG, PCI, and surgical 
procedures changed by 231%, 193%, and 99%, respectively. Until the end of 2014, a total of 
357,476 CAG, 131,309 PCI, and 60,831 surgical procedures had been performed, correspond-
ing to 249,445, 100,609, and 55,539 first-time patients, respectively. The DHR generally has 
a high level of completeness (1–missing) of each procedure (.90%) when compared to the 
National Patient Registry. Variables important for assessing the quality of care have a high level 
of completeness for surgery since 2000, and for CAG and PCI since 2010.
Conclusion: The DHR contains valuable data on cardiac invasive procedures, which makes it 
an important national monitoring and quality system and at the same time serves as a platform 
for research projects in the cardiovascular field.
Keywords: nationwide, coronary angiography, percutaneous coronary intervention, cardiac 
surgery
Introduction
Around the turn of the last century, Denmark was facing a relatively high cardiovascular 
mortality rate and a low utilization of invasive cardiac procedures compared to other 
Nordic countries.1,2 Consequently, Danish health care authorities initiated a compre-
hensive nationwide initiative (the Heart Plan) to improve diagnosis and treatment of 
cardiovascular disease. In order to monitor the Heart Plan, the Danish Heart Registry 
(DHR) was established in 1998. The plan resulted in an increase in the use of coro-
nary diagnostics and interventions and contributed to a continuous drop in mortality 
due to cardiovascular disease in Denmark.3 To ensure that patients continue to benefit 
from improved quality of life and survival, it is of paramount importance to surveil 
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that the extent of invasive procedures outweigh the risks and 
 document stable or improving quality of treatment throughout 
the country. Reporting data to the DHR was therefore made 
compulsory. Each operator at each hospital submits data 
to their local database (the East Denmark Heart Registry 
[EDHR] or the West Denmark Heart Registry [WDHR]4 
electronic database). All procedures, but with a selected set 
of data variables, are subsequently extracted from the EDHR 
and WDHR and reported to the DHR.
In Denmark, with a total population of 5,660,000 
( January 1, 2015), a unique and personal identifier number 
is assigned to each individual residing in Denmark at birth or 
upon immigration, which enables cross-linking data from the 
DHR with other nationwide registries. Hence, the National 
Patient Registry (NPR)5 and the Danish Civil Registration 
System6 are used to assess the DHR’s completeness of pro-
cedures and conduct mortality analyses, respectively.
Aim
The DHR monitors the quantity and quality of invasive pro-
cedures in different patient groups across all hospitals and 
serves as a data source for nationwide cardiovascular research 
within the field of ischemic heart and heart valve disease.
Study population
The DHR has been previously described;7 however, it 
 currently requires an expansion of other diagnostic and treat-
ment areas to be included in the registry. In its present form, 
the DHR holds information on all coronary angiography 
(CAG), percutaneous coronary intervention (PCI), coronary 
artery bypass grafting (CABG), and heart valve replacement 
performed on patients aged $15 years across the country. 
In the coming years, the DHR will also include national cov-
erage of transcatheter aortic valve implantation (TAVI) and 
coronary computed tomography angiography (CCTA).
The DHR contains nationwide data on PCI and surgi-
cal activities since 2000 and CAG procedures since 2006. 
However, at present, only the WDHR reports TAVI to the 
DHR. Between 2000 and 2014, the number of CAG, PCI, 
and surgical procedures changed by 231%, 193%, and 99%, 
respectively. By the end of 2014, a total of 357,476 CAG, 
131,309 PCI, and 60,831 surgical procedures had been 
registered in the DHR, corresponding to 249,445, 100,609, 
and 55,539 first-time patients, respectively. Figure 1 shows 
the trends of each procedure, including isolated CABG and 
heart valve surgery, among first-time patients.
As of 2014, 12 public and one private hospital carried out 
CAG across the country. Among these, PCI was performed in 
seven centers, of which one is a private hospital with a very 
low number of procedures. Four centers performed primary 
PCI around the clock and had facilities for urgent surgery if 
needed. In 2014, all public PCI centers performed at least 821 
PCI per center yearly. Four public and one privately funded 
hospital offered cardiac surgery.
In the future, the number of hospitals reporting to the 
DHR will increase, as hospitals performing CCTA also will 
contribute data to the DHR, of which the WDHR has already 
validated the CCTA data.8
Given the Danish reimbursement policy, hospitals are 
required to report procedures to the NPR as well. The 
completeness (1-missing) of each procedure registered in 
the DHR was measured as the percentage of registered pro-
cedures in the NPR, which was also registered in the DHR 
(Figure 2). Since the DHR released its first annual report 
in 2005,  covering data from 2003, a general high complete-
ness (.90%) of procedures has been reported, although 
for certain procedures a high level of completeness have 
been present since 2000. The NPR has national cover age 
on CAG from 2004, which is the earliest time from which 
comparison of CAG between the DHR and the NPR can be 
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Figure 1 Number of first-time patients in the Danish Heart Registry who received 
invasive procedures from 2000 to 2014.
Abbreviations: CAG, coronary angiography; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass grafting.
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Figure 2 Trends in the percentage of procedures registered in the Danish Heart 
Registry as well as in the National Patient Registry in relation to the number of 
procedures registered in the National Patient Registry.
Notes: CABG denotes all surgical procedures that at least include CABG. valve 
surgery denotes all surgical procedures that at least include valve surgery.
Abbreviations: CAG, coronary angiography; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass grafting.
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made. In 2008, TAVI was offered as a treatment for selected 
patients, but because only one regional database reported 
TAVI to the DHR, the consequence has been a somewhat 
lower estimate for valve surgery in recent years. In addi-
tion, between 2008 and 2011, the local clinical databases in 
East Denmark merged, resulting in missing data from one 
surgical hospital during 2009–2010. The data have been 
found and are now in the process of being loaded onto the 
database by the DHR’s data manager. Figure 2 reflects the 
impact of the missing surgical data from East Denmark. 
In comparison, the level of completeness for CAG, PCI, 
CABG, and valve surgery in the WDHR was in the range 
of 97%–98% in 2008.4
Main variables
Each invasive procedure is described by approximately 60–70 
unique variables that cover demographic characteristics, 
prognostic factors, and procedure-related complications. 
Table 1 provides an overview of the majority of the data 
variables registered in the DHR.
Based on these variables, an annual report is produced 
presenting key figures at the national and the center level. 
The report contains summary of activity,  waiting time, and 
prognostic factors such as indication, age, sex distribution, 
diabetics, emergency procedures, use of stent, and additive 
European System for Cardiac Operative Risk Evaluation 
(EuroSCORE) II, which replaced EuroSCORE I in 2015.
The report also includes quality indicators designed to 
evaluate the quality of care at a center level. These indicators 
cover procedure-related complications in CAG, PCI, CABG, 
and heart valve surgery and mortality following PCI, CABG, 
and heart valve surgery (Table 1). For each invasive proce-
dure up to 13 quality measures are provided and, if available, 
compared to performance standards, which are based on best 
available evidence or expert consensus for which there is no 
firm evidence available.
Variables describing CAG- and PCI-related complications 
include local vascular complications, X-ray dose, myocardial 
infarction, stroke, and emergency CABG surgery (for PCI 
only). Variables describing surgical complications comprise 
procedure-related myocardial infarction, stroke, length of 
stay in the intensive care unit, reoperations for bleeding, and 
deep sternal wound infection.
For each procedure, variable completeness (1-missing) 
was measured as the percentage of first-time patients with 
registered variable (Table 1). The majority of the variables 
reported in the annual report have a high level of complete-
ness (.90%). Variables with a low level of completeness 
(,90%) have a greater tendency of missing information 
between 2000 and 2010 (data not shown), at which point 
the Registry Support Centre of Clinical Quality and Health 
Informatics (KCKS-East) became the new data manager of 
the DHR. Between 2000 and 2014, variables used to assess 
the quality of surgical procedures had, in the majority of 
cases, a high level of completeness. In contrast, among the 
variables used to assess the quality of CAG and PCI, only 
X-ray dose had a high level of completeness. Since 2010, 
an improvement was noted across all quality variables in 
all procedures. The level of completeness was in the range 
of 91.9%–99.8% between 2010 and 2014 (data not shown). 
A previous validation study documented the low level of 
completeness for some variables. Between 2005 and 2006, 
200 randomly selected procedures in the DHR (50 CAG, 50 
PCI, 50 CABG, and 50 valve procedures) were validated 
against the local electronic database and the written patient 
records. In general, there was a good agreement, but some 
of the 28 variables being tested had a low level of complete-
ness, particularly for complication variables in CAG and PCI 
(.40% of completeness).9 The occurrence of missing data 
was most likely because of the lack of registration rather 
than problems with data transfer. However, in 2008, the 
WDHR4 had a higher level of completeness for certain PCI 
variables (contrast volume and number of treated arteries: 
100%) than what we reported herein (62.3% and 77.7%, 
respectively). Even though the WDHR covers 55% of the 
total Danish population, the comparison is impaired by the 
fact that this study was based on 2008 data only; nevertheless, 
this discrepancy raises concern regarding the quality of data 
transfer related to this period. Furthermore, since 2009, the 
data content has been updated. The most recent introduction 
of a new variable was in 2015. Hence, a period of time will 
elapse before meaningful analyses can be performed for 
some variables.
Follow-up
Multiple mechanisms are at work to ensure the data quality. 
Since 2010, each regional data source submits daily record 
on each procedure through a secure website, the DHR web 
service, which automatically checks if the validation rules are 
met. Once a record is accepted, the sender is notified and the 
record being a EXtensible Markup Language file (XML) is 
converted to a Statistical Analysis System (SAS) file, which 
is subsequently loaded into the DHR database. In contrast, 
when rejected, the sender is notified about the reason for 
rejection (eg, length of intensive care unit time exceeding 
more than 6 months). Further, during follow-up, each hospital 
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Table 1 The majority of the Danish Heart Registry’s data elements depicting the baseline characteristics of first-time patients 
undergoing CAG, PCI, and/or surgery and variable completeness between 2000 and 2014
Patient and procedure related 
characteristics
Baseline characteristicsa Variable completeness
CAG PCI Surgery CAG PCI Surgery
Number of patients 249,445 100,609 55,539 249,445 100,609 55,539
Age, years 63.8 (12.0) 64.5 (11.7) 65.8 (11.4) 100 100 100
Male sex, n (%) 23,0728 (66.0) 72,595 (72.2) 40,924 (73.7) 100 100 100
Height, cm 172.3 (9.5) 173.1 (9.2) 172.6 (9.2) 57.1 54.5 47.9
weight, kg 81.0 (17.4) 81.8 (16.5) 80.8 (16.1) 57.6 54.9 48.2
Smoking status (current or former), n (%) 154,536 (62.0) 64,990 (64.6) 30,021 (54.1) 90.2 86.7 80.9
Diabetes (with or without treatment), n (%) 33,275 (13.3) 12,739 (12.7) 7,940 (14.3) 93.6 89.6 85.0
Left ventricular ejection fraction 53.4 (13.7) 52.8 (13.1) – 47.0 40.2 –
Cardiac centers – – – 100 100 100
Clinical presentation – – – 92.4 92.5 –
 Acute, n (%) 42,787 (17.2) 33,012 (32.8) – – – –
 Subacute, n (%) 46,761 (18.7) 19,758 (19.6) – – – –
 Elective, n (%) 140,821 (56.5) 40,318 (40.1) – – – –
 Unknown, n (%) 19,076 (7.6) 7,521 (7.5) – – – –
Indication 92.7 87.9 –
 STEMI, n (%) 31,693 (12.7) 24,091 (23.9) – – – –
 NSTEMI/UAP, n (%) 58,787 (23.6) 25,433 (25.3) – – – –
 Stable angina, n (%) 80,978 (32.5) 29,678 (29.5) – – – –
 Other, n (%) 59,721 (23.9) 9,208 (9.2) – – – –
 Unknown, n (%) 18,266 (7.3) 12,199 (12.1) – – – –
Referral date – – – 98.1 94.7 61.9
Procedure date – – – 100 100 100
Procedure codes (NCSP)b – – – 62.7 81.9 50.7
Catheter size, Fr 5.9 (0.4) 6.0 (6.0, 6.0) – 61.6 61.3 –
Contrast volume, mL 70.0 (50.0, 100.0) 100.0 (70.0, 170.0) – 62.5 62.3 –
Fluoroscopy time, min 2.0 (1.0, 4.0) 6.70 (3.0, 12.0) – 99.2 99.1 –
X-ray dose, Gy cm2 25.0 (14.0, 44.0) 41.0 (20.0, 79.0) – 98.4 98.7 –
CAD severity – – – – 50.5 –
 1-vessel disease, n (%) 49,691 (19.9) – – – – –
 2-vessel disease, n (%) 13,706 (5.5) – – – – –
 3-vessel disease, n (%) 15,384 (6.2) – – – – –
 Diffuse CAD, n (%) 17,833 (7.1) – – – – –
 Normal, n (%) 29,414 (11.8) – – – – –
 Unknown, n (%) 123,417 (49.5) – – – – –
Number of stents – 1.0 (1.0, 2.0) – – 61.7 –
Number of treated lesions – 1.0 (1.0, 2.0) – – 99.5 –
Number of treated arteries – – – – 77.7 –
 1 vessel, n (%) – 65,844 (65.4) – – – –
 2 vessels, n (%) – 11,123 (11.1) – – – –
 3 vessels, n (%) – 1,203 (1.2) – – – –
 Unknown, n (%) – 22,439 (22.3) – – – –
Local vascular complications, n (%) 3,516 (1.4) 1,625 (1.6) – 77.5 80.0 –
Emergency CABG surgery, n (%) 1,555 (0.6) 422 (0.4) – 60.7 60.5 –
Surgery – – 99.2
 Isolated CABG, n (%) – – 31,663 (57.0) – – –
 Isolated valve surgery, n (%) – – 12,011 (21.6) – – –
 CABG and valve surgery, n (%) – – 4,622 (8.3) – – –
 Other, n (%) – – 6,801 (12.2) – – –
 Unknown, n (%) – – 442 (0.8) – – –
valvular surgery
 Aortic, n (%) – – 9,495 (17.1) – – 100
 Mitral, n (%) – – 2,694 (4.9) – – 100
 Tricuspid, n (%) – – 303 (0.6) – – 59.7
 Pulmonary, n (%) – – 145 (0.3) – – 59.7
(Continued)
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has access to their own data, enabling them to monitor their 
reports, and twice a year activity and waiting time for invasive 
procedures in the preceding 2-year period are presented for 
the National Board of Health. In addition, the yearly report 
undergoes critical review and approval by board members of 
the DHR before it is made available online.10
Examples of research
The DHR has served as a data source for several nationwide 
studies. Each annual report contains a list of performed and 
ongoing research. During 2000–2009, the number of first-
time CAG has been reported to have increased more than 
50%, and this was mostly attributed to patients with no prior 
history of ischemic heart disease. Furthermore, mean age, 
proportion of women, and use of prophylactic cardiovas-
cular drugs increased as well.11 Another study assessed the 
national trends in time to invasive examination and treat-
ment in non-ST segment elevation myocardial infarction 
(NSTEMI) and unstable angina between 2001 and 2009. 
This study demonstrated that utilization of CAG and PCI 
had increased as opposed to CABG and that the proportion 
of patients undergoing invasive examination and treatment 
within 3 days had increased.12 A study on first-time acute 
myocardial infarction without significant stenosis did not 
show any difference between the sexes in terms of the level 
of secondary preventive medicine and long-term mortality 
and recurrence of acute myocardial infarction.13 The Scan-
dinavian Organization for Randomized Trials with Clinical 
Outcome II performed a head-to-head comparison of the 
clinical efficacy and safety between the first two drug-eluting 
stents (DES [sirolimus-eluting Cypher and the pacllitaxel-
eluting Taxus stents]) in patients deemed suitable for DES 
and with STEMI, NSTEMI, or unstable/stable angina. No 
significant difference was observed after short- and long-
term follow-up.14,15
Administrative issues and funding
The DHR is administered and maintained by the Danish 
National Institute of Public Health (NIPH) and funded by the 
Danish Clinical Registries (RKKP). Since 2010 and 2014, 
KCKS-East, which serves under RKKP, has been responsible 
for the data management and delivery of data for research.
The structure of the DHR organization comprises three 
bodies – the board, the executive steering group, and the 
office. The DHR board includes representatives from selected 
organizations (the Danish Society of Cardiology [DCS], 
the Danish Society of Thoracic Surgery [DTS], the Danish 
Society of Anaesthesiology and Intensive Care Medicine, the 
Danish Society of Clinical Physiology and Nuclear Medicine, 
the RKKP, and the NIPH) and departments performing inva-
sive procedures. Hospitals performing only CAG are repre-
sented by two representatives, each representing the EDHR 
and the WDHR. The board is responsible for the overall 
strategy, development of goals, overseeing the organization 
management, approving the annual report, introducing new 
variables, revising the quality indicators, and updating the 
performance standards in collaboration with representatives 
from the DCS and the DTS. The board has appointed an 
executive steering group, which comprises the chairman, 
an interventionalist/surgeon, the NIPH representative, and 
a medical consultant. The executive steering group ensures 
the management of the DHR organization between the annual 
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Table 1 (Continued)
Baseline characteristicsa Variable completeness
CAG PCI Surgery CAG PCI Surgery
EuroSCORE – – 5.2 (3.5) – – 95.3
Extracorporal circulation, n (%) – – 43,168 (77.7) – – 97.0
ICU length of stay, hours – – 22.0 (20.0, 24.0) – – 86.0
Reoperation for bleeding, n (%) – – 3,124 (5.6) – – 94.1
Deep sternal wound infection, n (%) – – 549 (1.0) – – 92.4
Procedure-related myocardial  
infarction, n (%)
1,619 (0.6)c 513 (0.5)c 1,713 (3.1)d 79.4 80.1 91.3
Procedure-related stroke, n (%) 278 (0.1)c 353 (0.4)c 847 (1.5)e 62.6 62.3 91.2
vital status – – – 98.3 98.1 98.3
Notes: aContinuous variables are presented as means (SD) or medians (interquartile range), and categorical variables are presented as numbers (%). bNCSP codes are used 
to classify each procedure: CAG (UXAC40, UXAC85, UXAC90, UXUC85-UXUC87, UFYA20), PCI (KFNG00, KFNG02, KFNG05, KFNG10, KFNG12, KFNG20, KFNG22, 
KFNG30, KFNG40, KFNG96, KZFX01), CABG (KFNA-F, KFNH, KFNJ, KFNK, KFNw), valve surgery (KFG, KFK, KFJE, KFJF, KFM). cwithin 12 hours, dduring admission, 
eonset of symptoms within 12 hours and lasting .24 hours.
Abbreviations: CAG, coronary angiography; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST segment 
elevation myocardial infarction; UAP, unstable angina pectoris; NCSP, NOMESCO classification of surgical procedures; Fr, the French scale; CAD, coronary artery disease; 
CABG, coronary artery bypass grafting; EuroSCORE, European System for Cardiac Operative Risk Evaluation; ICU, intensive care unit; SD, standard deviation.
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board meetings and supervises the office located at the 
NIPH, which is responsible for the day-to-day administrative 
operations, implementing the changes set forth by the execu-
tive steering committee, handling incoming and outgoing 
communications, organizing the annual board meeting, and 
preparing the annual report.
The DHR is approved by the National Board of Health 
and the Danish Data Protection Agency (Reference number 
2007-58-0014).
Conclusion
The DHR contains valuable information on invasive cardiac 
procedures and serves its purpose as a national monitoring 
and quality control system. Cross-linking the DHR with a 
variety of national databases on an individual level makes it 
a powerful tool to secure continuous quality monitoring of 
cardiac interventions and surgical procedures on a nationwide 
level, as well as an important resource for cardiovascular 
research. The DHR looks forward to an expansion in the 
near future by including information on CCTA and TAVI, 
which enables monitoring of novel diagnostics and interven-
tions within cardiovascular care. However, the DHR is also 
faced with other challenges, as evidence suggests previous 
problems with the registration and the data transfer for some 
variables probably until 2010, at which point a new data 
manager has since then ensured the data quality by automatic 
validation. Finally, the continued expansion of the DHR 
entails the risk of data break for some variables, which also 
needs to be addressed in the near future.
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